We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ted Feldman

Ted Feldman MD, FESC, FACC, MSCAI

Director of the Cardiac Catheterization Laboratory, Walgreen Chair in Interventional Cardiology, Professor of Clinical Medicine at University of Chicago Medical School; Evanston Hospital, Evanston, Illinois

Dr. Feldman received his undergraduate and medical training at Indiana University, completing residency training as Chief Resident at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.  After finishing his Cardiology Fellowship at the University of Chicago, he remained there as Professor of Medicine and Director of the Cardiac Catheterization Laboratory.   

He currently practices at Evanston Hospital, where he is Director of the Cardiac Catheterization Laboratory, holds the Walgreen Chair in Interventional Cardiology, and is Professor of Clinical Medicine at University of Chicago Medical School.  He has authored over 500 manuscripts, chapters, abstracts, and editorials and edited or co-edited several books. He is a Percutaneous Coronary Intervention Guideline co-author and has served on the American Board of Internal Medicine Interventional Cardiology test writing committee. Chicago Magazine has repeatedly named him among Chicago’s Top Doctors.

Dr. Feldman is a past-President of the Society of Cardiovascular Angiography & Interventions, and chaired the Annual Scientific Sessions of the Society, as well as the American College of Cardiology Interventional Sessions. He is an active interventional practitioner and performs hundreds of catheter procedures every year. He has been the national principal investigator of the EVEREST MitraClip trial and the REPRISE III TAVR trial, and participates in numerous clinical investigations, with major research interests that include non-surgical, percutaneous repair of the mitral valve, catheter based aortic valve replacement, shunt closure for congenital heart disease, left atrial appendage closure, and development of new catheter devices.

Disclosures

Consultant & research grants: Abbott, BSC, Edwards